Core Laboratories Nv Stock Filter Stocks by Fundamentals
| CLB Stock | USD 11.40 0.25 2.15% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Core Laboratories' long-term financial health and intrinsic value.
Core | Shares Owned by Institutions | Build AI portfolio with Core Stock |
Core Laboratories ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Core Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Core Laboratories' managers, analysts, and investors.Environmental | Governance | Social |
Core Laboratories Institutional Holders
Institutional Holdings refers to the ownership stake in Core Laboratories that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Core Laboratories' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Core Laboratories' value.| Shares | Fred Alger Management, Llc | 2025-03-31 | 736.9 K | Btim Corp | 2025-03-31 | 610.9 K | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 589.6 K | Northern Trust Corp | 2025-03-31 | 531 K | Charles Schwab Investment Management Inc | 2025-03-31 | 498 K | Gendell Jeffrey L | 2025-03-31 | 457 K | Bank Of New York Mellon Corp | 2025-03-31 | 410.4 K | Hotchkis & Wiley Capital Management Llc | 2025-03-31 | 400.8 K | Van Eck Associates Corporation | 2025-03-31 | 395.1 K | Ariel Investments, Llc | 2025-03-31 | 10.3 M | Blackrock Inc | 2025-03-31 | 7.5 M |
Core Fundamentals
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.053 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 741.12 M | ||||
| Shares Outstanding | 46.88 M | ||||
| Shares Owned By Insiders | 1.00 % | ||||
| Shares Owned By Institutions | 99.00 % | ||||
| Number Of Shares Shorted | 7.86 M | ||||
| Price To Earning | 101.74 X | ||||
| Price To Book | 2.16 X | ||||
| Price To Sales | 1.03 X | ||||
| Revenue | 523.85 M | ||||
| Gross Profit | 102.39 M | ||||
| EBITDA | 73.27 M | ||||
| Net Income | 32.15 M | ||||
| Cash And Equivalents | 15.43 M | ||||
| Cash Per Share | 0.29 X | ||||
| Total Debt | 180.14 M | ||||
| Debt To Equity | 1.29 % | ||||
| Current Ratio | 2.23 X | ||||
| Book Value Per Share | 5.43 X | ||||
| Cash Flow From Operations | 56.39 M | ||||
| Short Ratio | 21.95 X | ||||
| Earnings Per Share | 0.59 X | ||||
| Price To Earnings To Growth | 1.67 X | ||||
| Target Price | 15.6 | ||||
| Number Of Employees | 3.4 K | ||||
| Beta | 1.41 | ||||
| Market Capitalization | 534.47 M | ||||
| Total Asset | 590.41 M | ||||
| Retained Earnings | 150.28 M | ||||
| Working Capital | 129.02 M | ||||
| Current Asset | 238.55 M | ||||
| Current Liabilities | 120.76 M | ||||
| Annual Yield | 0 % | ||||
| Five Year Return | 2.66 % | ||||
| Net Asset | 590.41 M | ||||
| Last Dividend Paid | 0.04 |
About Core Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Core Laboratories NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Core Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Core Laboratories NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:Check out Core Laboratories Piotroski F Score and Core Laboratories Altman Z Score analysis. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.896 | Dividend Share 0.04 | Earnings Share 0.59 | Revenue Per Share | Quarterly Revenue Growth (0.05) |
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.